Evidence map›Paper›PMID 42136639›Full record

ArticleFrontiers in immunology2026

Correction: Safety, tolerability, and concordance with interferon-γ release assays of a recombinant ESAT6-MPT64 skin test: a phase 1 randomized clinical trial.

Xichao Ou, Guan Liu, Baozhen Peng, Yuehua Li, Hegui Yan, Naihui Chu, Bing Zhao, Yanlin Zhao, Juan Du

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Xichao Ou *National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Beijing, China.
Guan Liu *Phase I Clincal Trial Center, Wuhan Pulmonary Hospital(Wuhan Institute for tuberculosis control), Wuhan, China.
Baozhen Peng *National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Beijing, China.
Yuehua LiPhase I Clincal Trial Center, Wuhan Pulmonary Hospital(Wuhan Institute for tuberculosis control), Wuhan, China.
Hegui YanPhase I Clincal Trial Center, Wuhan Pulmonary Hospital(Wuhan Institute for tuberculosis control), Wuhan, China.
Naihui ChuTuberculosis Department, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Bing ZhaoNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Beijing, China.
Yanlin ZhaoNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Beijing, China.
Juan DuPhase I Clincal Trial Center, Wuhan Pulmonary Hospital(Wuhan Institute for tuberculosis control), Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2026.1780294.].

Indexed as

Antigens, BacterialBacterial ProteinsInterferon-gammaInterferon-gamma Release TestsSkin TestsHumansRecombinant ProteinsAntigens, BacterialBacterial ProteinsInterferon-gammaRecombinant Proteinsdiagnostic accuracyESAT6-MPT64IGRA concordanceMPT64mycobacterium tuberculosisphase 1 clinical trialrecombinant skin test

Identifiers

PMID42136639
PMCPMC13169259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.